Owners and management
CVR: 45186660
Secondary names: CataVax A/S, Immune Cure A/S, Immune Genomics A/S
Not available
BITLINC ApS (5-9,99%), TASC HOLDING ApS (10-14,99%)
2 more
CVR · view owners
Anders Kaare Nørgaard
Board: Christian Erik Drejøe (chair) and 2 members
CVR · view management
Active
Founded 1 November 2024
CVR · view overview
No headcount reported
Owner registered: TASC HOLDING ApS
CVR · 13/01/2025
View the full event history
Catalyst Vaccination A/S is a Danish company of the type Aktieselskab based in Frederiksberg, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Kaare Nørgaard. The board consists of Christian Erik Drejøe (chair), Jens Hagenau and Søren Peder Tang Hansen. The company's owners include BITLINC ApS, TASC HOLDING ApS and MEDCED Capital Invest ApS.
Virksomhedens formål er at eje immaterielle rettigheder vedrørende immunsystemet og at investere i udvikling og salg af software og farmaceutiske produkter baseret på disse rettigheder.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of Catalyst Vaccination A/S is 45186660.
The owners of Catalyst Vaccination A/S include BITLINC ApS, TASC HOLDING ApS and MEDCED Capital Invest ApS.
The management of Catalyst Vaccination A/S consists of Anders Kaare Nørgaard.
The board of Catalyst Vaccination A/S consists of Christian Erik Drejøe, Jens Hagenau and Søren Peder Tang Hansen, with Christian Erik Drejøe as chair.
Catalyst Vaccination A/S was founded on 1 November 2024.
Catalyst Vaccination A/S is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Claim this page to add your logo and social links. Free to get started.
Catalyst Vaccination A/S has published its interim report for the period November 1, 2024 – December 31, 2025.
Contact info changed: new website: https://catavax.com (March 4, 2026).
Contact info changed: new website: https://catavax.com (January 15, 2026).
As of September 17, 2025, Jens Hagenau has joined the board of directors of Catalyst Vaccination A/S.
As of September 17, 2025, Anders Kaare Nørgaard has left the board of directors of Catalyst Vaccination A/S.
As of January 13, 2025, TASC HOLDING ApS is registered as an owner of Catalyst Vaccination A/S with an ownership share of 10%.
As of November 26, 2024, BITLINC ApS is registered as an owner of Catalyst Vaccination A/S with an ownership share of 5%.
As of November 1, 2024, Anders Kaare Nørgaard has joined the board of directors of Catalyst Vaccination A/S.
As of November 1, 2024, Søren Peder Tang Hansen has joined the board of directors of Catalyst Vaccination A/S.
As of November 1, 2024, Christian Erik Drejøe has joined the board of directors of Catalyst Vaccination A/S.
As of November 1, 2024, Anders Kaare Nørgaard is registered as adm. dir. of Catalyst Vaccination A/S.
As of November 1, 2024, MEDCED Capital Invest ApS is registered as an owner of Catalyst Vaccination A/S with an ownership share of 33%.
As of November 1, 2024, Tang Hansen Holding ApS is registered as an owner of Catalyst Vaccination A/S with an ownership share of 33%.
Catalyst Vaccination A/S was founded on November 1, 2024.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
